Literature DB >> 16235164

The role of race and gender in T cell responses in children perinatally infected with HIV-1.

Andrea Kovacs, Maria C Villacres.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16235164      PMCID： PMC3127256          DOI： 10.1086/462429

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  24 in total

1.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Both age and gender affect thymic output: more recent thymic migrants in females than males as they age.

Authors:  J Pido-Lopez; N Imami; R Aspinall
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 3.  Immune control of HIV: the obstacles of HLA and viral diversity.

Authors:  B D Walker; B T Korber
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

Review 4.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

5.  The relationships between ethnicity, sex, risk group, and virus load in human immunodeficiency virus type 1 antiretroviral-naive patients.

Authors:  J Saul; J Erwin; C A Sabin; R Kulasegaram; B S Peters
Journal:  J Infect Dis       Date:  2001-04-24       Impact factor: 5.226

6.  The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.

Authors:  H M Spiegel; R Chandwani; M E Sheehy; J Dobroszycki; G Fennelly; A Wiznia; J Radding; M Rigaud; H Pollack; W Borkowsky; M Rosenberg; D F Nixon
Journal:  J Infect Dis       Date:  2000-06-27       Impact factor: 5.226

7.  Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Authors:  K Luzuriaga; M McManus; M Catalina; S Mayack; M Sharkey; M Stevenson; J L Sullivan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Association of race and gender with HIV-1 RNA levels and immunologic progression.

Authors:  K Anastos; S J Gange; B Lau; B Weiser; R Detels; J V Giorgi; J B Margolick; M Cohen; J Phair; S Melnick; C R Rinaldo; A Kovacs; A Levine; S Landesman; M Young; A Muñoz; R M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

9.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

10.  Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.

Authors:  Elizabeth R Sharp; Jason D Barbour; R Karl Karlsson; Kimberly A Jordan; Johan K Sandberg; Andrew Wiznia; Michael G Rosenberg; Douglas F Nixon
Journal:  J Infect Dis       Date:  2005-10-05       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.